Table 4.
Preliminary efficacy results
| Outcome | n | Baseline | 6 months | Mean Change | 95% Confidence Interval | d |
| Hippocampal volume (mm3) | ||||||
| DIET | 5 | 3336 ± 557 | 3338 ± 506 | 2 ± 139 | ||
| ED | 7 | 3156 ± 262 | 3166 ± 291 | 10 ± 90 | ||
| Between group difference | 8 | (-164 to 179) | .11 | |||
| RAVLT | ||||||
| DIET | 7 | 9.00 ± 1.91 | 10.57 ± 2.51 | 1.57 ± 3.10 | ||
| ED | 7 | 9.86 ± 2.27 | 10.57 ± 2.15 | .71 ± 1.50 | ||
| Between group difference | .86 | (-2.11 to 3.82) | .35 | |||
| HbA1c (%) | ||||||
| DIET | 5 | 6.00 ± 0.29 | 5.52 ± 0.18 | -.48 ± .19 | ||
| ED | 7 | 5.76 ± 0.57 | 5.71 ± 0.55 | -.05 ± .05 | ||
| Between group difference | .43 | (.20 to .67) | 1.02 | |||
| Vitamin K (nmol/L) | ||||||
| DIET | 5 | 1.24 ± 0.39 | 1.45 ± 1.24 | .21 ± .88 | ||
| ED | 7 | 2.65 ± 1.61 | 1.93 ± 0.98 | -.90 ± 1.25 | ||
| Between group difference | 1.11 | (-.26 to 2.48) | .70 | |||
| BEI score (out of 14) | ||||||
| DIET | 7 | 6.43 ± 1.06 | 9.36 ± 1.28 | 2.93 ± 1.13 | ||
| ED | 7 | 7.21 ± 1.60 | 7.07 ± 1.67 | -.14 ± 2.19 | ||
| Between group difference | 3.07 | (.96 to 5.18) | 1.75 | |||
| V̇O2peak (ml/kg/min) | ||||||
| DIET | 5 | 22.16 ± 5.35 | 24.20 ± 5.82 | 2.04 ± .88 | ||
| ED | 6 | 20.13 ± 3.64 | 22.53 ± 3.23 | 2.40 ± 2.81 | ||
| Between group difference | .36 | (-3.31 to 2.59) | .17 |